Şunu aradınız:: dosisregulering (Danca - İngilizce)

dosisregulering
dose regulation

der kan ikke gives anbefaling om dosisregulering.
no recommendation on a dose adjustment can be made.

dosisregulering bør baseres på klinisk respons og tolerabilitet.
dose escalation should be based upon clinical response and tolerability.

dosisregulering er ikke nødvendig hos patienter, der oplever forsinket nyretransplantatfunktion postoperativt (se pkt.
no dose adjustments are needed in patients experiencing delayed renal graft function post-operatively.

de foreliggende data antyder ikke et behov for en dosisregulering med eylea hos disse patienter (se pkt.
available data do not suggest a need for a dose adjustment with eylea in these patients (see section 5.2)

dosisregulering er ikke nødvendig hos patienter, der oplever forsinket nyretransplantatfunktion post- operativt (se pkt.
no dose adjustments are needed in patients experiencing delayed renal graft function post-operatively (see section 5.2).

der findes ingen data, der indikerer, at dosisregulering af omeprazol eller esomeprazol kan kompensere for den observerede farmakokinetiske interaktion.
there are no data available indicating that omeprazole or esomeprazole dose adjustments will overcome the observed pharmacokinetic interaction.

patienter med leverinsufficiens der behøves ingen justering af initialdosis ej heller af dosisregulering for patienter med leverinsufficiens (se pkt.5. 2) .
hepatic impaired patients no adjustments of the starting dose nor of the dose modification rules are required in hepatic impaired patients (see section 5.2) .

dosisregulering er ikke nødvendig hos patienter med nedsat nyrefunktion (kreatininclearance 4 ml/min) (se afsnit 5. 2) .
no dosage adjustment is necessary in patients with impaired renal function (creatinine clearance 4 ml/min) (see section 5.2) .

patienter med nedsat nyrefunktion dosisregulering er ikke nødvendig hos patienter med nedsat nyrefunktion (kreatininclearance > 4 ml/ min) (se afsnit 5. 2).
24 patients with renal impairment no dosage adjustment is necessary in patients with impaired renal function (creatinine clearance > 4 ml/ min) (see section 5.2).